Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients.

Gang NingYongqiang LiWenji ChenWenjuan TangDi-Wen ShouQingling LuoHui-Ting Chen Yong Jian Zhou

Published in: Journal of oncology (2021)

A risk signature was developed and validated for early prediction of HCC development, which may be a useful tool to set up individualized follow-up interval schedules.

Keyphrases

early stage
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
radiation therapy
patient reported outcomes